Kathryn Hassell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathryn Hassell has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Betty Pace
Department of Molecular and Cell Biology, University of Texas at Dallas, Dallas, TX
1 shared publicationCage S. Johnson
Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
1 shared publicationJames Eckman
Department of Hematology/Oncology, Emory School of Medicine, Atlanta, GA
1 shared publicationNaomi Luban
Department of Laboratory Medicine and Pathology, Children's National Medical Center, Washington, DC
1 shared publicationPeter Lane
Aflac Cancer Center and Blood Disorder Service, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
1 shared publicationRoshni Kulkarni
Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI
1 shared publication
Latest Publications
- 1 December 2008
- Published by Elsevier in Thrombosis Research
- Vol. 123, S16-S21
Heparin-Induced Thrombocytopenia: Diagnosis and Management
- 1 December 2008
- Published by Elsevier in Thrombosis Research
- Vol. 123, S16-S21
Heparin-Induced Thrombocytopenia: Diagnosis and Management
- Open Access
- 18 October 2008
- Published by Wiley in American Journal of Hematology
- Vol. 84 (1) , 39-45
Sickle Cell Disease Summit: From clinical and research disparity to action
The American Society of Pediatric Hematology/Oncology Sickle Cell Summit brought together a broad range of constituencies to identify a unified approach to healthcare and research disparities for sickle cell disease. Recommendations included the following: (1) speak with a unified voice representing all constituencies; (2) optimize access to care from knowledgeable health care providers and create a medical home for all individuals with the disease; (3) utilize population‐based surveillance to measure outcomes; (4) develop overall approaches to basic, translational, clinical, and health services research; (5) enhance the community role in advocacy, education, service, and fundraising. Taskforces were identified to effect implementation. Am. J. Hematol., 2009.
- 18 October 2008
- Published by Wiley in American Journal of Hematology
- Vol. 84 (1) , 39-45
Open AccessSickle Cell Disease Summit: From clinical and research disparity to action
The American Society of Pediatric Hematology/Oncology Sickle Cell Summit brought together a broad range of constituencies to identify a unified approach to healthcare and research disparities for sickle cell disease. Recommendations included the following: (1) speak with a unified voice representing all constituencies; (2) optimize access to care from knowledgeable health care providers and create a medical home for all individuals with the disease; (3) utilize population‐based surveillance to measure outcomes; (4) develop overall approaches to basic, translational, clinical, and health services research; (5) enhance the community role in advocacy, education, service, and fundraising. Taskforces were identified to effect implementation. Am. J. Hematol., 2009.
- 1 October 2005
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 19 (5) , 903-916
Pregnancy and Sickle Cell Disease
- 1 October 2005
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 19 (5) , 903-916
Pregnancy and Sickle Cell Disease
- 1 February 2005
- Published by Elsevier in Cardiology Clinics
- Vol. 23 (1) , 65-71
Hematologic ramifications of patent foramen ovale—role of hypercoagulable state
- 1 February 2005
- Published by Elsevier in Cardiology Clinics
- Vol. 23 (1) , 65-71
Hematologic ramifications of patent foramen ovale—role of hypercoagulable state